Valens Semiconductor (VLN) Q4 2024 earnings summary

Executive summary

• 2024 was challenging due to inventory digestion and weak customer markets, but a turnaround is expected in 2025 with new design wins, product launches, and the acquisition of Acroname.

• 2024 revenue reached $57.9M, with a diversified customer base across ProAV, automotive, industrial, and medical sectors.

• Over 40M chipsets sold, 125 patents, and ~$0.5B cumulative R&D investment highlight technological leadership.

• Positioned as a market leader in high-speed, long-reach, error-free connectivity solutions, with strong partnerships and industry standards adoption.

• A five-year plan aims to quadruple revenues, targeting high-growth markets like industrial machine vision and medical endoscopy.

Financial highlights

• Q4 2024 revenue was $16.7M, exceeding guidance and marking the fourth consecutive quarter of growth.

• Full year 2024 revenue was $57.9M, down from $84.2M in 2023, with CIB at $36.3M and automotive at $21.6M.

• Q4 gross margin was 60.4%, above the midpoint of guidance; adjusted EBITDA loss was $3.7M, better than expected.

• GAAP net loss for 2024 was $36.6M, with adjusted EBITDA loss of $21.1M.

• Ended 2024 with $148.4M in cash and no debt; working capital was $183.3M.

Outlook and guidance

• 2025 revenue expected between $71M–$76M, representing 23%–31% year-over-year growth.

• Q1 2025 revenue guidance is $16.3M–$16.6M, with gross margin of 60.8%–61.3% and adjusted EBITDA loss of $4.5M–$4.2M.

• Five-year plan targets $220M–$300M revenue by 2029, with gross margin of 50%–60% and EBITDA margin of 15%–20%.

• Growth drivers include new product adoption (VS6320, VA7000), automotive design wins, and potential acquisitions.